HK1079198A1 - Nobel process for the preparation of pyrazolopyrimidiones - Google Patents

Nobel process for the preparation of pyrazolopyrimidiones

Info

Publication number
HK1079198A1
HK1079198A1 HK05111131A HK05111131A HK1079198A1 HK 1079198 A1 HK1079198 A1 HK 1079198A1 HK 05111131 A HK05111131 A HK 05111131A HK 05111131 A HK05111131 A HK 05111131A HK 1079198 A1 HK1079198 A1 HK 1079198A1
Authority
HK
Hong Kong
Prior art keywords
pyrazolopyrimidiones
nobel
preparation
compound
general formula
Prior art date
Application number
HK05111131A
Other languages
English (en)
Inventor
Mark Edward Bunnage
Philip Charles Levett
Nicholas Murray Thomson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26244537&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1079198(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0015462A external-priority patent/GB0015462D0/en
Priority claimed from GB0105878A external-priority patent/GB0105878D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of HK1079198A1 publication Critical patent/HK1079198A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HK05111131A 2000-06-22 2005-12-06 Nobel process for the preparation of pyrazolopyrimidiones HK1079198A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0015462A GB0015462D0 (en) 2000-06-22 2000-06-22 Novel process for the preparation of pyrazolopyrimidinones
GB0105878A GB0105878D0 (en) 2001-03-09 2001-03-09 Novel process for the preparation of pyrazoloprimidinones
PCT/IB2001/001038 WO2001098303A1 (en) 2000-06-22 2001-06-07 Novel process for the preparation of pyrazolopyrimidinones

Publications (1)

Publication Number Publication Date
HK1079198A1 true HK1079198A1 (en) 2006-03-31

Family

ID=26244537

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05111131A HK1079198A1 (en) 2000-06-22 2005-12-06 Nobel process for the preparation of pyrazolopyrimidiones

Country Status (26)

Country Link
EP (1) EP1296983B1 (xx)
JP (1) JP2004501154A (xx)
KR (1) KR100525699B1 (xx)
AP (1) AP2001002195A0 (xx)
AR (1) AR028729A1 (xx)
AT (1) ATE282619T1 (xx)
AU (2) AU2001262592B2 (xx)
BR (1) BR0111864A (xx)
CA (1) CA2411957C (xx)
CZ (1) CZ20024130A3 (xx)
DE (1) DE60107248T2 (xx)
ES (1) ES2231498T3 (xx)
GT (2) GT200100113A (xx)
HK (1) HK1079198A1 (xx)
HU (1) HUP0301207A3 (xx)
IL (1) IL152983A0 (xx)
MX (1) MXPA02012887A (xx)
MY (1) MY127737A (xx)
PA (1) PA8520001A1 (xx)
PE (1) PE20020091A1 (xx)
PL (1) PL360299A1 (xx)
PT (1) PT1296983E (xx)
SV (1) SV2002000502A (xx)
TN (1) TNSN01092A1 (xx)
WO (1) WO2001098303A1 (xx)
YU (1) YU84702A (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2310144B1 (es) 2007-06-15 2010-01-12 Galenicum Health, S.L. Intermedios para la preparacion de un inhibidor de la fosfodiesterasa tipo 5.
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
US6087368A (en) * 1998-06-08 2000-07-11 Bristol-Myers Squibb Company Quinazolinone inhibitors of cGMP phosphodiesterase
CA2347950C (en) * 1998-10-23 2005-05-03 Pfizer Inc. Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction

Also Published As

Publication number Publication date
GT200100113AA (es) 2006-04-10
SV2002000502A (es) 2002-07-03
PA8520001A1 (es) 2003-09-05
PE20020091A1 (es) 2002-02-21
MXPA02012887A (es) 2003-05-14
EP1296983B1 (en) 2004-11-17
TNSN01092A1 (fr) 2005-11-10
KR100525699B1 (ko) 2005-11-03
CA2411957A1 (en) 2001-12-27
DE60107248D1 (de) 2004-12-23
HUP0301207A2 (hu) 2003-08-28
PL360299A1 (en) 2004-09-06
ATE282619T1 (de) 2004-12-15
CA2411957C (en) 2007-09-18
CZ20024130A3 (cs) 2004-01-14
EP1296983A1 (en) 2003-04-02
AU6259201A (en) 2002-01-02
YU84702A (sh) 2005-09-19
DE60107248T2 (de) 2005-12-01
HUP0301207A3 (en) 2006-02-28
MY127737A (en) 2006-12-29
ES2231498T3 (es) 2005-05-16
AU2001262592B2 (en) 2006-07-06
WO2001098303A1 (en) 2001-12-27
AP2001002195A0 (en) 2002-12-21
KR20030017556A (ko) 2003-03-03
BR0111864A (pt) 2003-07-01
GT200100113A (es) 2002-06-04
JP2004501154A (ja) 2004-01-15
PT1296983E (pt) 2005-02-28
AR028729A1 (es) 2003-05-21
IL152983A0 (en) 2003-06-24

Similar Documents

Publication Publication Date Title
AU7278500A (en) Fungicides
IL160440A (en) Dihydropteridinones, method for producing the same and the use thereof as medicaments
SE0004245D0 (sv) Novel compounds and their use
AU2002210425A1 (en) Novel beta-amyloid inhibitors, method for producing the same and the use thereofas medicaments
CA2309474A1 (en) New 4-arylpiperidine derivatives for the treatment of pruritus
BG105766A (en) New process for preparing pesticidal intermediates
AU6339000A (en) Serotonergic benzothiophenes
AU2002365378A1 (en) Process for preparing 3,3',6,6'-tetraalkyl-2,2'-biphenols and 3,3',6,6'-tetraalkyl-5,5'-dihalo-2,2'-biphenols
MXPA03011401A (es) Procedimiento para la preparacion de derivados de ciclohexanol.
WO2002016322A3 (en) Process for the preparation of 2-aminoethylpyridines
IN187760B (xx)
HK1079198A1 (en) Nobel process for the preparation of pyrazolopyrimidiones
BG106002A (en) Process for preparing pesticidal intermediates
GB0019124D0 (en) Novel process
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
PL343546A1 (en) Processes for preparing intermediates
AU8459401A (en) Process for preparing a substituted imidazopyridine compound
GB9920959D0 (en) Novel process
CA2276310A1 (en) Process for the production of tetrazolylbenzopyrans
AU2001277801A1 (en) Process for preparing 2,3-diaminopropanols and synthesis of other compounds using 2,3-diaminopropanols
AU2356501A (en) Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments
SE0101323D0 (sv) New process
SE0000382D0 (sv) New process
AU4132199A (en) Method for producing 4,4-dimethyl-5alpha-cholesta-8,14,24-triene-3beta-ol and intermediate products obtained by said method
AU4865201A (en) An intermediate and process for its synthesis

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110607